Skip to main content

MetaMorphix, Cargill Complete Whole Genome Association Study in Beef Cattle

NEW YORK, June 7 (GenomeWeb News) - MetaMorphix and Cargill said today that they have completed the first whole cattle genome association study and developed tools that could identify cattle that meet certain quality and consistency levels.

 

The companies entered their exclusive research and development deal in June 2002.

 

MetaMorphix said that it had previously identified and characterized a dense map of novel genetic markers based on single nucleotide polymorphisms in beef cattle. It then conducted a whole genome association study in a population of commercial cattle in a Cargill feedlot and discovered specific regions in the cattle genome associated with desirable beef traits.

 

The companies said that over the next year, the tools will be validated in Cargill feedlots in order to examine their potential use in commercial cattle production.

 

"The creation of this unique set of markers in the bovine genome will permit the development of a product that we expect will aid the cattle feedlot technology aimed at production of superior cattle and beef," Albert Paszek, director of animal productivity and genomics at Cargill, said in a statement. "We look forward to working with MetaMorphix to bring this innovation to the cattle industry."

 

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.